PFKFB3 and pulmonary edema: Indeed, novel strategies targeting metabolic regulatory genes have been proved successful against endotheliopathy, e.g., Pfkfb3 knockout protected from pulmonary oedema upon lipopolysaccharide-shock via reduced glycolysis and decreased concomitant endothelial permeability, vascular cell adhesion and immune infiltration [59].